https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/adjustment-of-warrants-granted-for-services https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/aoci https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/available-for-sale-debt-maturities-single-maturity-date https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/available-for-sale-debt-maturities-single-maturity-date-amortized-cost-basis https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/available-for-sale-debt-maturities-within-one-year-amortized-cost https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/available-for-sale-debt-maturities-within-one-year-fair-value https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/available-for-sale-debt-noncurrent https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/cash https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/common-stock-no-par-value https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/debt-carrying-amount https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/debt-unamortized-discount https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-income-tax-assets-net https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-offering-costs https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-revenue-2 https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-revenue-recognized https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-foreign https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/deferred-taxes-acquisition-valuation-allowance-available-to-reduce-income-tax-expense https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/dividends-declared https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/due-from-related-parties https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/effective-tax-rate https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/foreign-currency-transaction-gain-before-tax https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/foreign-currency-transaction-loss-before-tax https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/foreign-earnings https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/foreign-pretax-income https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/government-assistance-amount https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/income-loss-from https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/income-tax-rate-reconciliation-deductions-employee-stock-ownership-plan-dividends https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/income-tax-receivable https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/income-taxes-paid https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/insider-transactions-other https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/insider-transactions-preferred/purchases https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/insider-transactions-warrants https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/interest-expense-other https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/interest-income-expense-net https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/interest-income-other https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/interest-paid-net https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/interest-receivable https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/investment-income-interest https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/investments https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/investments-fair-value-disclosure https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/lease-and-rental-expense https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/lease-cost https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/letters-of-credit-outstanding-amount https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/liability-for-uncertain-tax-positions-current https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/long-term-debt https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/long-term-investments https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/net-income-loss-from-discontinued-operations-available-to-common-shareholders-basic https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/noninterest-expense-offering-cost https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-lease-assets https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-lease-cost https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-lease-liability https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-lease-liability-current https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-lease-payments https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/other-current-assets https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/other-income https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/other-liabilities-fair-value-disclosure https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/other-noncash-income-expense https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/paid-in-kind-interest https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/prepaid-insurance https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/pretax-income-domestic https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/proceeds-from-sale-maturity-and-collections-of-investments https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/receivables-net-current https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/redeemable-preferred-stock-dividends https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/research-and-development-in-process https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/restricted-cash https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/restricted-cash-current https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/restricted-cash-noncurrent https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/short-term-investments https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-award-rsu-forfeitures-grant-date-fair-value https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stock-split-ratio https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/tax-credit-carryforward-amount https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/tax-rate-reconciliation-fdii-amount https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/tax-rate-reconciliation-share-based-compensation-excess-tax-benefit-amount https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/tax-reconciliation-tax-credits https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/tax-reconciliation-tax-credits-foreign https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/total-long-term-debt https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/unrealized-gain-loss-on-investments https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/variable-lease-cost https://stock.noler.com/us/stock/fusion-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted